| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $241K | +7.1% |
| Cost of Revenue | $874K | +17.8% |
| R&D Expense | $12.5M | +22.7% |
| SG&A Expense | $7.9M | +16.2% |
| Operating Income | -$22.3M | -15.7% |
| Interest Expense | $1.6M | +94.9% |
| Pre-tax Income | -$23.8M | -14.2% |
| Net Income | -$23.8M | -14.2% |
| EPS (Basic) | -$1.23 | +17.4% |
| EPS (Diluted) | -$1.23 | +17.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $34K | -10.5% |
| Inventory | $1.5M | -9.5% |
| Current Assets | $6.3M | -33.1% |
| Total Assets | $8.6M | -25.8% |
| Current Liabilities | $11.6M | +53.4% |
| Total Liabilities | $20.3M | -33.1% |
| Stockholders' Equity | -$12.2M | +35.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.2M | -1.4% |
| Capital Expenditures | $179K | -81.7% |
| Investing Cash Flow | -$179K | +81.7% |
| Financing Cash Flow | $16.6M | -17.7% |
| Free Cash Flow | -$18.4M | +2.9% |